Jyong Biotech Ltd. Ordinary Shares

MENS

Biotechnology · Healthcare

Price

$2.18

+0.02 (+0.93%)

Market Cap

$165.7M

Exchange

NASDAQ

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Share count falling — buybacks

−4.0% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 76.0M (2021) → 73.0M (2025)

Winston Score History

The full picture

Jyong Biotech Ltd. is a biotechnology company focused on developing medical and health-related products. The company operates in the healthcare sector, working on treatments or therapies aimed at improving patient outcomes. Like many small biotech firms, it targets medical professionals, hospitals, or patients as its end customers.

Jyong Biotech is a small-cap company with a market capitalization of roughly $0.2 billion. Its gross and operating margins are currently near zero, which is common for early-stage biotech companies that are still spending heavily on research and development before generating meaningful product revenue. The notably high reported ROIC figure may reflect accounting quirks rather than established profitability. The company appears to have limited geographic reach compared to larger global peers. The key risk here is typical of small biotechs: the company must successfully advance its pipeline through clinical trials and regulatory approvals to generate sustainable revenue, and failure at any stage could significantly impact its future.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-290.7% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$731,000/ year

↓ Declining (-21% vs prior year)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

63.1%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$1M cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

—

Data not available

Profit after running costs

Operating Margin

N/A

—

Data not available

Return on the money invested

ROCE

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

—

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

1/4 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

—

Data not available

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial